Zamann Pharma Support logo

Siedlerstraße 7 | 68623 Lampertheim, Germany

info@zamann-pharma.com

Request an appointment now

Innovations and highlights in the Pharma industry 

Dive deep into the world of Pharma with Zamann’s Expert Blog. Our industry-leading professionals share insights on global project management, quality consultancy, digitalization, and more. Stay updated with trends and innovations transforming the Pharma industry. 

News and more

Biotech Hubs Are Expanding; Why GMP Complexity Is Rising Across Pharma

Emerging Biotech Hubs across North America, Europe, and Asia are attracting new pharmaceutical investments, research facilities, and global talent in 2026. While this expansion reflects strong industry growth, it also introduces new GMP Compliance challenges, validation demands, and Quality Systems
  • News
Biotech Hubs Are Expanding; Why GMP Complexity Is Rising Across Pharma

Good Manufacturing Practice in UK in 2026: MHRA GMP Inspection Guide

Learn how good manufacturing practice in UK supports successful MHRA inspections through risk-based quality systems, data integrity, validation, and effective CAPA. Discover the latest UK GMP expectations and practical strategies to improve inspection readiness and long-term regulatory compliance.
  • Blog, Quality Management System
Pharmaceutical manufacturing UK facility prepared for MHRA GMP inspection with cleanroom operations, quality management, and GMP compliance controls.

FDA Rare Disease Shift 2026; New Regulatory Risks Pharma Teams Must Track

The U.S. Food and Drug Administration (FDA) is facing growing attention over how it evaluates Rare Disease Therapies in 2026. Discussions around FDA Advisory Committees (AdComms) and patient-focused decision-making highlight a broader regulatory transformation that may reshape how pharmaceutical companies
  • News
FDA Rare Disease Shift 2026; New Regulatory Risks Pharma Teams Must Track

Good Manufacturing Practices in Malaysia in 2026: NPRA GMP Inspection Guide

Learn how Malaysia GMP guidelines and NPRA GMP inspections align with PIC/S GMP requirements. This guide explains pharmaceutical quality systems, inspection priorities, common findings, CAPA expectations, and practical strategies to improve GMP compliance and inspection readiness.
  • Blog, Quality Management System
NPRA GMP inspection in a pharmaceutical manufacturing Malaysia facility following PIC/S GMP requirements and pharmaceutical quality system standards

One Leadership Change, Hidden GMP Risks; Why Quality Systems Start to Fail

Leadership experts in the healthcare sector have warned that organizational strategies often become vulnerable during executive transitions when they rely on individual leaders instead of institutional governance. Although the discussion originated from healthcare leadership, its implications extend directly to Pharmaceutical
  • News
One Leadership Change, Hidden GMP Risks; Why Quality Systems Start to Fail

FDA Approves Subcutaneous Isatuximab; Why PK Bridging May Redefine Future Biologic Approvals

The U.S. Food and Drug Administration (FDA) has approved the subcutaneous formulation of isatuximab-irfc (Sarclisa Escena) for three multiple myeloma treatment regimens, expanding an anti-CD38 therapy that was previously available only as an intravenous infusion. While the approval offers patients
  • News
FDA Approves Subcutaneous Isatuximab; Why PK Bridging May Redefine Future Biologic Approvals

FDA Freezes CRL Transparency; What Changes for Pharma Compliance

The FDA has paused the public release of new Complete Response Letters (CRLs) while reviewing a citizen petition that challenges the legal basis of the disclosure program. The decision temporarily interrupts one of the agency’s most significant transparency initiatives and
  • News
FDA Freezes CRL Transparency; What Changes for Pharma Compliance

MindRank Secures $52M; AI-Designed Drugs Move Beyond Discovery

Artificial intelligence has taken another step from research into regulated drug development. Chinese biotech MindRank has secured $52 million in Series B funding to advance its AI-powered drug discovery platform and accelerate the clinical development of its oral GLP-1 receptor
  • News
MindRank Secures $52M; AI-Designed Drugs Move Beyond Discovery